Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vipin Arora

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Crohn'S & Colitis 360|February 13, 2023
Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative ColitisMarla C Dubinsky, Remo Panaccione, James D Lewis, et al.
Journal of Cellular Physiology|December 27, 2019
Absence of VEGFR-1/Flt-1 signaling pathway in mice results in insensitivity to discogenic low back pain in an established disc injury mouse modelSujun Qiu, Changgui Shi, Arivarasu Natarajan Anbazhagan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2014
Adalimumab for the treatment of Japanese patients with intestinal Behçet's diseaseSatoshi Tanida, Nagamu Inoue, Kiyonori Kobayashi, et al.
The New England Journal of Medicine|February 16, 2017
Baricitinib versus Placebo or Adalimumab in Rheumatoid ArthritisPeter C Taylor, Edward C Keystone, Désirée van der Heijde, et al.
Inflammatory Bowel Diseases|March 9, 2024
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension StudyBruce E Sands, Geert D'Haens, David B Clemow, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Crohn'S & Colitis 360|February 13, 2023
Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative ColitisMarla C Dubinsky, Remo Panaccione, James D Lewis, et al.
Journal of Cellular Physiology|December 27, 2019
Absence of VEGFR-1/Flt-1 signaling pathway in mice results in insensitivity to discogenic low back pain in an established disc injury mouse modelSujun Qiu, Changgui Shi, Arivarasu Natarajan Anbazhagan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2014
Adalimumab for the treatment of Japanese patients with intestinal Behçet's diseaseSatoshi Tanida, Nagamu Inoue, Kiyonori Kobayashi, et al.
The New England Journal of Medicine|February 16, 2017
Baricitinib versus Placebo or Adalimumab in Rheumatoid ArthritisPeter C Taylor, Edward C Keystone, Désirée van der Heijde, et al.
Inflammatory Bowel Diseases|March 9, 2024
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension StudyBruce E Sands, Geert D'Haens, David B Clemow, et al.
Pageof 8